EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments

Go back to EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments
(NASDAQ: EYPT) Delayed: 4.02 +0.17 (4.42%)
Previous Close $3.85    52 Week High
Open $3.87    52 Week Low
Day High $4.10    P/E N/A 
Day Low $3.80    EPS
Volume 3,861,469